Which has better valuation and earnings, DXCM or ABT?

Abbott Laboratories has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 6.17 $836.30M $2.34 31.85 Abbott Laboratories $44.33B 4.13 $6.52B $3.09 34.25

Does the media favor DXCM or ABT?

In the previous week, Abbott Laboratories had 21 more articles in the media than DexCom. MarketBeat recorded 58 mentions for Abbott Laboratories and 37 mentions for DexCom. Abbott Laboratories' average media sentiment score of 1.11 beat DexCom's score of 0.96 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 19 Very Positive mention(s) 1 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Abbott Laboratories 40 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer ISRG or ABT?

In the previous week, Abbott Laboratories had 3 more articles in the media than Intuitive Surgical. MarketBeat recorded 58 mentions for Abbott Laboratories and 55 mentions for Intuitive Surgical. Abbott Laboratories' average media sentiment score of 1.11 beat Intuitive Surgical's score of 1.06 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 40 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Abbott Laboratories 40 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer ABT or TSLA?

In the previous week, Tesla had 256 more articles in the media than Abbott Laboratories. MarketBeat recorded 314 mentions for Tesla and 58 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.11 beat Tesla's score of 0.14 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 40 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive Tesla 105 Very Positive mention(s) 47 Positive mention(s) 57 Neutral mention(s) 75 Negative mention(s) 27 Very Negative mention(s) Neutral

Does the media favor ABBV or ABT?

In the previous week, AbbVie had 21 more articles in the media than Abbott Laboratories. MarketBeat recorded 79 mentions for AbbVie and 58 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.11 beat AbbVie's score of 0.95 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AbbVie 47 Very Positive mention(s) 5 Positive mention(s) 20 Neutral mention(s) 1 Negative mention(s) 3 Very Negative mention(s) Positive Abbott Laboratories 40 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to ABT or BSX?

In the previous week, Boston Scientific had 33 more articles in the media than Abbott Laboratories. MarketBeat recorded 91 mentions for Boston Scientific and 58 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.11 beat Boston Scientific's score of 0.59 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 40 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive Boston Scientific 38 Very Positive mention(s) 11 Positive mention(s) 16 Neutral mention(s) 17 Negative mention(s) 1 Very Negative mention(s) Positive

Abbott Laboratories (ABT) Competitors

$105.83 -2.17 (-2.01%)

Closing price 07/30/2026 03:59 PM Eastern

Extended Trading

$104.70 -1.13 (-1.06%)

As of 08:17 AM Eastern

Compare

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

Should you buy Abbott Laboratories stock or one of its competitors? MarketBeat compares Abbott Laboratories with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Abbott Laboratories include DexCom (DXCM), Intuitive Surgical (ISRG), Tesla (TSLA), AbbVie (ABBV), and Boston Scientific (BSX).

How does Abbott Laboratories compare to DexCom?

DexCom (NASDAQ:DXCM) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

In the previous week, Abbott Laboratories had 21 more articles in the media than DexCom. MarketBeat recorded 58 mentions for Abbott Laboratories and 37 mentions for DexCom. Abbott Laboratories' average media sentiment score of 1.11 beat DexCom's score of 0.96 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	19 Very Positive mention(s)	1 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	40 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive

97.8% of DexCom shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.3% of DexCom shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Abbott Laboratories has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	6.17	$836.30M	$2.34	31.85
Abbott Laboratories	$44.33B	4.13	$6.52B	$3.09	34.25

DexCom has a net margin of 19.31% compared to Abbott Laboratories' net margin of 11.65%. DexCom's return on equity of 33.33% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	19.31%	33.33%	13.19%
Abbott Laboratories	11.65%	17.69%	9.44%

DexCom has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market.

DexCom currently has a consensus target price of $84.71, suggesting a potential upside of 13.64%. Abbott Laboratories has a consensus target price of $118.17, suggesting a potential upside of 11.67%. Given DexCom's higher possible upside, analysts clearly believe DexCom is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89
Abbott Laboratories	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92

Summary

Abbott Laboratories beats DexCom on 9 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

Intuitive Surgical has a net margin of 28.45% compared to Abbott Laboratories' net margin of 11.65%. Abbott Laboratories' return on equity of 17.69% beat Intuitive Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.45%	16.91%	14.83%
Abbott Laboratories	11.65%	17.69%	9.44%

Intuitive Surgical currently has a consensus price target of $509.02, suggesting a potential upside of 44.21%. Abbott Laboratories has a consensus price target of $118.17, suggesting a potential upside of 11.67%. Given Intuitive Surgical's higher probable upside, equities research analysts clearly believe Intuitive Surgical is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	20 Buy rating(s)	0 Strong Buy rating(s)	2.66
Abbott Laboratories	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92

Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$11.03B	11.30	$2.86B	$8.73	40.43
Abbott Laboratories	$44.33B	4.13	$6.52B	$3.09	34.25

In the previous week, Abbott Laboratories had 3 more articles in the media than Intuitive Surgical. MarketBeat recorded 58 mentions for Abbott Laboratories and 55 mentions for Intuitive Surgical. Abbott Laboratories' average media sentiment score of 1.11 beat Intuitive Surgical's score of 1.06 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	40 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Abbott Laboratories	40 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.6% of Intuitive Surgical shares are owned by insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Intuitive Surgical has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

Summary

Intuitive Surgical beats Abbott Laboratories on 10 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to Tesla?

Abbott Laboratories (NYSE:ABT) and Tesla (NASDAQ:TSLA) are related large-cap companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

In the previous week, Tesla had 256 more articles in the media than Abbott Laboratories. MarketBeat recorded 314 mentions for Tesla and 58 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.11 beat Tesla's score of 0.14 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	40 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive
Tesla	105 Very Positive mention(s)	47 Positive mention(s)	57 Neutral mention(s)	75 Negative mention(s)	27 Very Negative mention(s)	Neutral

Abbott Laboratories has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market. Comparatively, Tesla has a beta of 1.8, indicating that its share price is 80% more volatile than the broader market.

Abbott Laboratories currently has a consensus target price of $118.17, suggesting a potential upside of 11.67%. Tesla has a consensus target price of $402.24, suggesting a potential upside of 30.24%. Given Tesla's higher probable upside, analysts plainly believe Tesla is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92
Tesla	4 Sell rating(s)	19 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.42

Abbott Laboratories has higher earnings, but lower revenue than Tesla. Abbott Laboratories is trading at a lower price-to-earnings ratio than Tesla, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	4.13	$6.52B	$3.09	34.25
Tesla	$103.62B	11.77	$3.79B	$1.08	285.97

Abbott Laboratories has a net margin of 11.65% compared to Tesla's net margin of 3.67%. Abbott Laboratories' return on equity of 17.69% beat Tesla's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	11.65%	17.69%	9.44%
Tesla	3.67%	3.82%	2.27%

75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 66.2% of Tesla shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by company insiders. Comparatively, 19.9% of Tesla shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Abbott Laboratories beats Tesla on 9 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to AbbVie?

AbbVie (NYSE:ABBV) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

AbbVie currently has a consensus price target of $269.29, indicating a potential upside of 4.55%. Abbott Laboratories has a consensus price target of $118.17, indicating a potential upside of 11.67%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Abbott Laboratories is more favorable than AbbVie.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AbbVie	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.84
Abbott Laboratories	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92

In the previous week, AbbVie had 21 more articles in the media than Abbott Laboratories. MarketBeat recorded 79 mentions for AbbVie and 58 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.11 beat AbbVie's score of 0.95 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AbbVie	47 Very Positive mention(s)	5 Positive mention(s)	20 Neutral mention(s)	1 Negative mention(s)	3 Very Negative mention(s)	Positive
Abbott Laboratories	40 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive

70.2% of AbbVie shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.1% of AbbVie shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Abbott Laboratories has lower revenue, but higher earnings than AbbVie. Abbott Laboratories is trading at a lower price-to-earnings ratio than AbbVie, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AbbVie	$61.16B	7.44	$4.23B	$2.03	126.88
Abbott Laboratories	$44.33B	4.13	$6.52B	$3.09	34.25

AbbVie pays an annual dividend of $6.92 per share and has a dividend yield of 2.7%. Abbott Laboratories pays an annual dividend of $2.52 per share and has a dividend yield of 2.4%. AbbVie pays out 340.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories pays out 81.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. AbbVie has raised its dividend for 53 consecutive years and Abbott Laboratories has raised its dividend for 54 consecutive years.

AbbVie has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

Abbott Laboratories has a net margin of 11.65% compared to AbbVie's net margin of 5.79%. Abbott Laboratories' return on equity of 17.69% beat AbbVie's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AbbVie	5.79%	-576.45%	13.39%
Abbott Laboratories	11.65%	17.69%	9.44%

Summary

Abbott Laboratories beats AbbVie on 14 of the 20 factors compared between the two stocks.

How does Abbott Laboratories compare to Boston Scientific?

Abbott Laboratories (NYSE:ABT) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, media sentiment, institutional ownership and dividends.

In the previous week, Boston Scientific had 33 more articles in the media than Abbott Laboratories. MarketBeat recorded 91 mentions for Boston Scientific and 58 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.11 beat Boston Scientific's score of 0.59 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	40 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive
Boston Scientific	38 Very Positive mention(s)	11 Positive mention(s)	16 Neutral mention(s)	17 Negative mention(s)	1 Very Negative mention(s)	Positive

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Boston Scientific is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	4.13	$6.52B	$3.09	34.25
Boston Scientific	$20.07B	3.40	$2.90B	$2.39	19.21

Abbott Laboratories has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by company insiders. Comparatively, 0.3% of Boston Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Boston Scientific has a net margin of 17.50% compared to Abbott Laboratories' net margin of 11.65%. Boston Scientific's return on equity of 19.36% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	11.65%	17.69%	9.44%
Boston Scientific	17.50%	19.36%	10.99%

Abbott Laboratories currently has a consensus price target of $118.17, suggesting a potential upside of 11.67%. Boston Scientific has a consensus price target of $71.62, suggesting a potential upside of 55.96%. Given Boston Scientific's higher probable upside, analysts clearly believe Boston Scientific is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	1 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	3 Strong Buy rating(s)	2.92
Boston Scientific	2 Sell rating(s)	4 Hold rating(s)	24 Buy rating(s)	1 Strong Buy rating(s)	2.77

Summary

Abbott Laboratories beats Boston Scientific on 10 of the 17 factors compared between the two stocks.

Get Abbott Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ABT vs. The Competition

Export

Metric	Abbott Laboratories	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$186.88B	$9.14B	$7.04B	$23.55B
Dividend Yield	2.33%	2.53%	2.65%	4.19%
P/E Ratio	34.25	19.34	27.69	30.73
Price / Sales	4.13	6.95	485.60	81.96
Price / Cash	15.45	18.70	51.74	31.18
Price / Book	3.54	3.38	10.16	4.66
Net Income	$6.52B	$230.22M	$3.60B	$1.07B
7 Day Performance	2.62%	4.00%	0.66%	0.55%
1 Month Performance	16.70%	0.09%	-3.29%	1.58%
1 Year Performance	-16.12%	1.97%	24.49%	17.66%

Abbott Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ABT Abbott Laboratories	4.4287 of 5 stars	$105.83 -2.0%	$118.17 +11.7%	-17.7%	$186.88B	$44.33B	34.25	115,000	Positive News Analyst Forecast Analyst Revision
DXCM DexCom	3.9894 of 5 stars	$75.69 -1.3%	$85.36 +12.8%	-16.3%	$29.58B	$4.66B	32.35	11,000	Trending News Earnings Report Analyst Forecast Insider Trade
ISRG Intuitive Surgical	4.6631 of 5 stars	$353.17 +2.2%	$523.46 +48.2%	-29.5%	$122.33B	$10.06B	40.45	17,021	Trending News Analyst Upgrade
TSLA Tesla	4.7099 of 5 stars	$369.57 -3.0%	$408.07 +10.4%	-3.2%	$1.43T	$94.83B	339.06	134,785	Trending News Analyst Forecast
ABBV AbbVie	4.1493 of 5 stars	$253.37 -0.4%	$267.67 +5.6%	+35.8%	$449.63B	$62.82B	124.81	57,000	Trending News Analyst Forecast Options Volume Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ABT) was last updated on 7/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Abbott Laboratories (ABT) Competitors

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

How does Abbott Laboratories compare to DexCom?

Summary

How does Abbott Laboratories compare to Intuitive Surgical?

Summary

How does Abbott Laboratories compare to Tesla?

Summary

How does Abbott Laboratories compare to AbbVie?

Summary

How does Abbott Laboratories compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABT vs. The Competition

Abbott Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Abbott Laboratories (ABT) Competitors

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

How does Abbott Laboratories compare to DexCom?

Does the media favor DXCM or ABT?

Do institutionals & insiders hold more shares of DXCM or ABT?

Which has better valuation and earnings, DXCM or ABT?

Is DXCM or ABT more profitable?

Which has more risk & volatility, DXCM or ABT?

Do analysts rate DXCM or ABT?

Summary

How does Abbott Laboratories compare to Intuitive Surgical?

Is ISRG or ABT more profitable?

Do analysts recommend ISRG or ABT?

Which has better earnings & valuation, ISRG or ABT?

Does the media prefer ISRG or ABT?

Do insiders & institutionals hold more shares of ISRG or ABT?

Which has more volatility and risk, ISRG or ABT?

Summary

How does Abbott Laboratories compare to Tesla?

Does the media prefer ABT or TSLA?

Which has more volatility and risk, ABT or TSLA?

Do analysts rate ABT or TSLA?

Which has better valuation and earnings, ABT or TSLA?

Is ABT or TSLA more profitable?

Do institutionals and insiders have more ownership in ABT or TSLA?

Summary

How does Abbott Laboratories compare to AbbVie?

Do analysts rate ABBV or ABT?

Does the media favor ABBV or ABT?

Do insiders and institutionals hold more shares of ABBV or ABT?

Which has stronger earnings and valuation, ABBV or ABT?

Is ABBV or ABT a better dividend stock?

Which has more volatility and risk, ABBV or ABT?

Is ABBV or ABT more profitable?

Summary

How does Abbott Laboratories compare to Boston Scientific?

Does the media refer more to ABT or BSX?

Which has better earnings & valuation, ABT or BSX?

Which has more volatility & risk, ABT or BSX?

Do insiders and institutionals hold more shares of ABT or BSX?

Is ABT or BSX more profitable?

Do analysts prefer ABT or BSX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABT vs. The Competition

Abbott Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools